| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0019 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0064 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |